Tomer Gold

Technik-/Wissenschafts-/F&E-Leiter bei Dexcel Pharma Technologies Ltd.

52 Jahre

Health Technology

Consumer Services

Aktive Positionen von Tomer Gold

Unternehmen	Position	Beginn	Ende
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2011	-

Unternehmen	Position	Beginn	Ende
CYNAPSUS THERAPEUTICS INC	Direktor/Vorstandsmitglied	09.05.2013	21.10.2016
CYNAPSUS THERAPEUTICS INC	Independent Dir/Board Member	04.08.2014	21.10.2016

Technion-Israel Institute of Technology

Graduate Degree

International

Israel	3
Kanada	2

Operativ

Director/Board Member	1
Independent Dir/Board Member	1
Graduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Cynapsus Therapeutics, Inc. Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada.	Health Technology
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Health Technology